VALMONT DAILY VEIL. MOISTURIZING FACE FLUID MINERAL SUNSCREEN- zinc oxide cream

Valmont Daily Veil. Moisturizing Face Fluid Mineral Sunscreen by

Drug Labeling and Warnings

Valmont Daily Veil. Moisturizing Face Fluid Mineral Sunscreen by is a Otc medication manufactured, distributed, or labeled by Innovation Labs, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredient

Zinc Oxide 17.5%

Purpose

Sunscreen

Uses

• Helps prevent sunburn.
• If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

Warnings

For External use only.

Do not use

• on damaged or broken skin.

When using this product

• keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

• rash occurs.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• apply liberally 15 minutes before sun exposure.
• reapply at least every 2 hours.
• use a water-resistant sunscreen if swimming or sweating.

Sun Protection Measures:

• Spending time in the sun increases your risk of skin cancer and early skin aging.  To decrease this risk, regularly use a sunscreen with broad spectrum SPF value of 15 or higher and other sun protection measures including:
•    limit time in the sun, especially from 10 a.m. - 2 p.m.
•    wear long-sleeve shirts, pants, hats and sunglasses.
•    children under 6 months of age: Ask a doctor 

Other Information

Protect the product in this container from excessive heat and direct sunlight.

Inactive Ingredients

C15-19 alkane, hydrogenated polydecene, squalane, water, caprylic/capric triglyceride, silica, octyldodecanol, synthetic fluorphlogopite, propanediol, ethylene/propylene/styrene copolymer, isoamyl laurate, disteardimonium hectorite, polyhydroxystearic acid, argania spinosa kernel oil, methylsilanol mannuronate, polyglyceryl-2 oleate, tocopheryl acetate, silanediol salicylate, propylene carbonate, fragrance, ethylhexylglycerin, lecithin, isostearic acid, polyglyceryl-3 polyricinoleate, polyglyceryl-2 stearate, tocopherol, butylene/ethylene/styrene copolymer, urea, glycerin, bisabolol, potassium sorbate, pentaerythirtyl tetra-di-t-butyl hydroxyhdrocinnamate, phenoxyethanol, RNA, decarboxy carnosine HCL, butylene glycol, pentylene glycol, sodium acetylated hyaluronate, sodium hyaluronate, sodium hyaluronate crosspolymer, hydrolyzed sodium hyaluronate

Questions or Comments

1-866-411-8256

Valmont Daily Veil Moisturizing Face Sunscreen 73248-508-00

INGREDIENTS AND APPEARANCE

VALMONT DAILY VEIL. MOISTURIZING FACE FLUID MINERAL SUNSCREEN 
zinc oxide cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 73284-508
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37)	ZINC CATION	175 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
C15-19 ALKANE (UNII: CI87N1IM01)
HYDROGENATED POLYDECENE TYPE I (UNII: U333RI6EB7)
SQUALANE (UNII: GW89575KF9)
WATER (UNII: 059QF0KO0R)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
OCTYLDODECANOL (UNII: 461N1O614Y)
MAGNESIUM POTASSIUM ALUMINOSILICATE FLUORIDE (UNII: YK3DC63Y5M)
PROPANEDIOL (UNII: 5965N8W85T)
ISOAMYL LAURATE (UNII: M1SLX00M3M)
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)
POLYHYDROXYSTEARIC ACID (2300 MW) (UNII: YXH47AOU0F)
ARGAN OIL (UNII: 4V59G5UW9X)
METHYLSILANOL ASCORBATE (UNII: 46Z5D1I0IS)
POLYGLYCERYL-2 OLEATE (UNII: 5759J47SAM)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
SILANEDIOL SALICYLATE (UNII: C054DF30K0)
PROPYLENE CARBONATE (UNII: 8D08K3S51E)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
ISOSTEARIC ACID (UNII: X33R8U0062)
POLYGLYCERYL-3 PENTARICINOLEATE (UNII: 7Q0OK5DOT4)
POLYGLYCERYL-2 STEARATE (UNII: 253MC0P0YV)
TOCOPHEROL (UNII: R0ZB2556P8)
UREA (UNII: 8W8T17847W)
GLYCERIN (UNII: PDC6A3C0OX)
LEVOMENOL (UNII: 24WE03BX2T)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) (UNII: 255PIF62MS)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
RNA-BINDING MOTIF PROTEIN 39 (UNII: 7CGZ92983T)
DECARBOXY CARNOSINE HYDROCHLORIDE (UNII: 6X7K9I5QR7)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
PENTYLENE GLYCOL (UNII: 50C1307PZG)
SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93)
HYALURONIC ACID (UNII: S270N0TRQY)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
SODIUM S-(2-HYDROXY-3-(3-(TRIHYDROXYSILYL)PROPOXY)PROPYL) SULFUROTHIOATE (UNII: 2V56GQW1BM)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 73284-508-00	1 in 1 CARTON	01/07/2024
1		30 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	01/07/2024

Labeler - Innovation Labs, Inc. (117109069)